Document Detail


Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
MedLine Citation:
PMID:  20648074     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Diabetes mellitus is a major health concern in the modern world. Several sight-threatening ocular conditions are included in the array of health problems associated with this disease. Understandably, 2 of the more sight-threatening problems, proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME), have received a great deal of attention in recent years. Pivotal studies, such as the Early Treatment Diabetic Retinopathy Study and the Diabetic Retinopathy Study, have established laser photocoagulation as the accepted treatment modality. The last decade has seen a surge in clinical data supporting the use of pharmacologic therapy in place of the often damaging laser therapy. Supporting data are based on the establishment of vascular endothelial growth factor (VEGF) as a key facilitator of disease progression in diabetic retinopathy. We will discuss the advantages and disadvantages of both selective and pan-blockade anti-VEGF agents available today in an effort to help guide physicians wishing to use these agents to treat PDR and DME.
Authors:
Gian Paolo Giuliari; D Aaron Guel; Maria Angelica Cortez; Rafael T Cortez
Related Documents :
2611574 - Abnormal eating attitudes in young insulin-dependent diabetics.
1600854 - Risk factors for progression of microvascular complications in the stockholm diabetes i...
16367734 - A five-year follow-up on the temporal stability of the ego impairment index.
7141384 - Host defense mellitus: defective membrane synthesis during phagocytosis.
3555494 - The effects of insulin-like growth factor-i and insulin on placental lactogen productio...
12773304 - Insulin effects on acetate metabolism.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie     Volume:  45     ISSN:  0008-4182     ISO Abbreviation:  Can. J. Ophthalmol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0045312     Medline TA:  Can J Ophthalmol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  501-8     Citation Subset:  IM    
Affiliation:
Massachusetts Eye and Research Surgery Institution, Cambridge, Mass., USA. gpgiuliari@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of focal retinal function using multifocal electroretinography in patients with X-linked ...
Next Document:  Relation between blue-on-yellow perimetry and optical coherence tomography in normal tension glaucom...